Source:http://linkedlifedata.com/resource/pubmed/id/17379743
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-6-20
|
pubmed:abstractText |
Umbilical cord blood (UCB) has been used as a potential source of various kinds of stem cells, including hematopoietic stem cells, mesenchymal stem cells, and endothelial progenitor cells (EPCs), for a variety of cell therapies. Recently, EPCs were introduced for restoring vascularization in ischemic tissues. An appropriate procedure for isolating EPCs from UCB is a key issue for improving therapeutic efficacy and eliminating the unexpected expansion of nonessential cells. Here we report a novel method for isolating EPCs from UCB by a combination of negative immunoselection and cell culture techniques. In addition, we divided EPCs into 2 subpopulations according to the aldehyde dehydrogenase (ALDH) activity. We found that EPCs with low ALDH activity (Alde-Low) possess a greater ability to proliferate and migrate compared to those with high ALDH activity (Alde-High). Moreover, hypoxia-inducible factor proteins are up-regulated and VEGF, CXCR4, and GLUT-1 mRNAs are increased in Alde-Low EPCs under hypoxic conditions, while the response was not significant in Alde-High EPCs. In fact, the introduction of Alde-Low EPCs significantly reduced tissue damage in ischemia in a mouse flap model. Thus, the introduction of Alde-Low EPCs may be a potential strategy for inducing rapid neovascularization and subsequent regeneration of ischemic tissues.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
151-60
|
pubmed:meshHeading |
pubmed-meshheading:17379743-Aldehyde Dehydrogenase,
pubmed-meshheading:17379743-Animals,
pubmed-meshheading:17379743-Cell Movement,
pubmed-meshheading:17379743-Cell Proliferation,
pubmed-meshheading:17379743-Cell Separation,
pubmed-meshheading:17379743-Endothelial Cells,
pubmed-meshheading:17379743-Fetal Blood,
pubmed-meshheading:17379743-Humans,
pubmed-meshheading:17379743-Ischemia,
pubmed-meshheading:17379743-Mice,
pubmed-meshheading:17379743-Stem Cell Transplantation,
pubmed-meshheading:17379743-Stem Cells,
pubmed-meshheading:17379743-Transplantation, Heterologous,
pubmed-meshheading:17379743-Treatment Outcome,
pubmed-meshheading:17379743-Up-Regulation
|
pubmed:year |
2007
|
pubmed:articleTitle |
Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood.
|
pubmed:affiliation |
Graduate School of Comprehensive Human Sciences, Department of Regenerative Medicine, University of Tsukuba, Tsukuba, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|